How Can We Help You?

Quick Info:

Find a Doctor Specialties (800) 213-3284

Go To Home PageBack

Pancreatic Cancer Trails

Select Clinical Trial

Protocol Number: Boston Biomedical Inc. CanStem 111P – Pancreatic

Protocol Title: Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma.

Eligibility: Patient Population:  18 years and older;  metastatic pancreatic ductal adenocarcinoma; must not have previously received chemotherapy or any investigational agent; has one or more metastatic tumors evaluable by CT scan with contrast (or MRI, if patient is allergic to CT contrast media); life-expectancy of > 12 weeks.

Contact Information: (910) 715-2200


Clara McLean House
Make a Donation
News & Events